Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 25,685
-105 (-0.41%)
Oct 13, 2026, 3:29 PM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 545.88 billion as of October 13, 2026. Its market cap has decreased by 14.87% in one year.
Market Cap
545.88B
Enterprise Value
525.28B
Revenue
70.04B
Global Rank
n/a
Country Rank
n/a
PE Ratio
33.81
ChartMarket Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 545.88B, an increase of 11,345.77%. That is a compound annual growth rate of 21.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 545.88B | -11.63% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.10T |
| Cipla | 1.05T |
| Mankind Pharma | 978.18B |
| Aurobindo Pharma | 974.11B |
| Glenmark Pharmaceuticals | 647.09B |
| Alkem Laboratories | 631.18B |
| Gland Pharma | 505.09B |
| Ipca Laboratories | 485.95B |